Online Conference Center

 

Return to Vaccination News Home Page (for best results, right click to "open in new window")

Subscribe to the Vaccination NewsLetter

View past & current Scandals (columns by Sandy Mintz)

Search This Site using keywords

 

SCHAFER AUTISM REPORT                "Healing Autism:

                             No Finer a Cause on the Planet" ________________________________________________________________

Friday, November 21, 2003  EARLY FRIDAY EDITION  Vol. 7  No. 234

 

 

 --- > PROMOTE YOUR MEETINGS, CHAPTER OR CONFERENCE

             No Cost to List

       In the Largest, Widest Read "The Autism Calendar"tm

       http://home.sprynet.com/~schafer/frm/calendar-form.htm

 --- > NOTE CALENDAR DEADLINE ** Nov 24 ** FOR DEC UPDATE

 

 

      RESEARCH - News Article

   * Autism Project Draws Praise, Funding Questions

 

      RESEARCH - Abstracts. Contains technical language.

   * Use of Complementary And Alternative Treatments For Children With

     Autistic Spectrum Disorders Is Increasing.

   * Model of Autism: Increased Ratio of Excitation/Inhibition

     In Key Neural Systems.

   * Molecular Dissection Of The Amygdala And Its Relevance To Autism.

   * The Amygdala & Autism: Implications From Non-Human Primate Studies

   * Bioinformatic Analysis Of Autism Positional Candidate Genes Using

     Biological Databases And Computational Gene Network Prediction.

   * Hearing Impairment And Psychopathological Disorders In Children

     And Adolescents. Review of the Recent Literature.

   * Increases In Social Initiation Toward An Adolescent With Autism:

     Reciprocity Effects.

   * Infections, Toxic Chemicals And Dietary Peptides Binding To

     Lymphocyte Receptors And Tissue Enzymes Are Major Instigators

     of Autoimmunity In Autism.

 

 

 

Autism Project Draws Praise, Funding Questions

 

      [By Barbara Feder Ostrov and Jessica Portner for the San Jose Mercury News.] http://www.bayarea.com/mld/mercurynews/news/7307251.htm < -  - Address ends here.

 

 

  A federal plan designed to find the cause of autism within 10 years and create new treatments for many patients drew praise from parents and experts around California, but some doubt as to whether lawmakers will back up the proposal's lofty goals with funding.

      Autism affects as many as 1.5 million Americans, according to estimates based on federal statistics. In California, nearly 23,000 people, mostly children, receive state services for autism, with the number of cases doubling in the past four years, according to the state Department of Developmental Services. No one knows what causes autism, which typically surfaces in the first three years of life and can profoundly interfere with social interaction, communication and reasoning ability.

      The so-called federal autism “road map” establishes priorities for scientific research on the causes of autism, detecting it early and developing the most effective treatments. Its goals are ambitious: Federal officials hope not only to find the cause of autism within seven to 10 years, but also to prevent up to a quarter of all autism cases and create therapies that will allow 90 percent of autistic children to speak. The plan, developed by an interagency autism committee at the National Institutes of Health, has no price tag yet, and lawmakers have not discussed how much they might spend on it.

      Experts are discussing the plan at a major autism conference this week in Washington, D.C., sponsored by the Department of Education and the Department of Health and Human Services.

      “We really don't know that much about autism. There aren't a lot of facts,” said David Amaral, a University of California-Davis autism expert who worked on the plan. “This will set us on a journey to start uncovering some of those facts. We have a catastrophic problem on our hands.” The plan will help coordinate previously disorganized research efforts and help spur lawmakers to set aside more money for the fight against autism, said Amaral, research director at UC-Davis' Medical Investigation of Neurodevelopment Disorders (MIND) Institute.

      “Before, there was no attempt to pull it all together,” Amaral said. “You have to have a plan before you can even request additional funding.” Some parents are skeptical that money will be coming soon. Rick Rollens, parent of an autistic child who helped found the MIND Institute, said he was encouraged that the government's overall plan could jump-start autism research around the country. But its goals will not be realized, he said, unless the government devotes a minimum $500 million toward research, identification and treatment.

      “There is no dollar amount dedicated to this, and it is a public health crisis,” he said. “Short of that, anything would be window-dressing.” Rollens and other parents of autistic children regard the disease as an epidemic that threatens not only their children's futures but California's financial health. The state Department of Developmental Services spent more than $211 million for autism services in fiscal year 2001-2002 alone, said agency spokesman Paul Verke. More recent data was not available, he said.

      Some epidemiologists believe that better diagnosis and changing demographics help explain the rise in autism cases, but UC-Davis and state researchers have found that those factors alone cannot account for the spike in cases.

      “There is a sense of urgency in California, and we are pleased the federal government is responding,” said Santi Rogers, director of the San Andreas Regional Center, which serves 9,800 developmentally disabled Bay Area residents, including autistic children. “But we are in a hurry to get a lot of stuff done. People are waiting and are in extreme need of action.” The road map sets a timeline of one to 10 years to achieve a number of research and treatment goals. Scientists will work on a project to determine the genetic and environmental causes of autism, including identifying “biomarkers,” such as genes or blood proteins, that signal a child is vulnerable to developing the disorder.

      Researchers also will work on ways to screen children early for the disease, when intensive therapies can seemingly work miracles for some children. Children will be followed for years to determine the most effective behavioral therapies and medical treatments. Scientists also hope to categorize different types of autism to more effectively target drugs and other therapies, Amaral said.

      Gaynelle Grover of Los Altos has autistic twin boys who, after years of therapy, have developed into social, affectionate second-graders despite their condition. She welcomes federal attention to the issue, but said the government's goal to provide adequate services to children within seven to 10 years will leave many families who can't afford intensive therapy searching for help.

      “I am glad something like this is happening,” Grover said. “It's difficult for a parent with a child who wants answers now. As a child grows, it gets harder and harder for the parents and the child. The window of opportunity is when children are very young.” The plan, to be refined at this week's autism summit in Washington, D.C., will be scrutinized by lawmakers deciding how much money to devote to autism research in next year's federal budget.

      “We're finally starting to get a critical mass of researchers,” said Amaral. “Over the next decade, we're going to see some real progress.”

 

 

 

                 -- > DO SOMETHING ABOUT AUTISM NOW < --

 

                            SUBSCRIBE. . . !

            . . .Read, then Forward the Schafer Autism Report.

                (Delivered Fresh Daily to Your Emailbox)

            To Subscribe http://home.sprynet.com/~schafer/

                Or mailto:subs@doitnow.com    No Cost!

           _______________________________________________________

 

 

* * *

 

Use of Complementary And Alternative Treatments For Children With Autistic Spectrum Disorders Is Increasing.

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14606219&dopt=Abstract

 

Levy SE, Hyman SL.

Division of Child Development and Rehabilitation, Children's Seashore House, Children's Hospital of Philadelphia, PA, USA.

 

Interventions considered to be CAM are in constant flux.

      New treatments emerge, older treatments become less popular, and the cycle recurs.

      Data supporting new treatments should be scrutinized for scientific study design, clinical safety, and scientific validity.

      Many families approach the clinician armed with brochures, handouts, and printouts from Web sites that are dedicated to the care and support of parents and children with ASD.

      A recent web search using "autism and detoxification" resulted in almost 8,000 sites.

      The Defeat Autism Now! (DAN!) Project arose in 1995 from collaboration of members of the Autism Research Institute.

      The DAN! Project advocates a specific and extensive protocol for diagnosis and treatment and can be viewed at http://www.autism.com/ari/#dan.

      The scientific validation and support for many interventions is incomplete and disparate from the recommendation in the American Academy of Pediatrics Policy Statement.

      Families should be encouraged to discuss all proposed investigations or treatments they wish to try with their primary care provider so the practitioner can serve as the medical home (Sidebar, page 688).

      The clinician should communicate and collaborate with the family and educational professionals to encourage objective identification of what works.

      With increasing access to health information and societal pressure for families to actively participate in their health management, continued growth of interest in CAM can be anticipated.

      Clinicians must remember that parents may have different beliefs regarding the effectiveness of treatment and different tolerance for treatment risks.

      Practitioners must keep avenues of communication open, remain open-minded, and not assume a "don't ask, don't tell" posture in the context of providing a medical home to the increasing number of children diagnosed with autism.

      PMID: 14606219 [PubMed - in process]

* * *

 

Model of Autism: Increased Ratio of Excitation/Inhibition In Key Neural Systems.

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14606691&dopt=Abstract

 

Rubenstein JL, Merzenich MM.

Nina Ireland Laboratory of Developmental Neurobiology, Center for Neurobiology and Psychiatry, Department of Psychiatry, University of California at San Francisco, San Francisco, CA 94143-0984, USA. jlrr@itsa.ucsf.edu

 

Autism is a severe neurobehavioral syndrome, arising largely as an inherited disorder, which can arise from several diseases.

      Despite recent advances in identifying some genes that can cause autism, its underlying neurological mechanisms are uncertain.

      Autism is best conceptualized by considering the neural systems that may be defective in autistic individuals.

      Recent advances in understanding neural systems that process sensory information, various types of memories and social and emotional behaviors are reviewed and compared with known abnormalities in autism.

      Then, specific genetic abnormalities that are linked with autism are examined.

      Synthesis of this information leads to a model that postulates that some forms of autism are caused by an increased ratio of excitation/inhibition in sensory, mnemonic, social and emotional systems.

      The model further postulates that the increased ratio of excitation/inhibition can be caused by combinatorial effects of genetic and environmental variables that impinge upon a given neural system.

      Furthermore, the model suggests potential therapeutic interventions.

      PMID: 14606691 [PubMed - in process]

* * *

 

Molecular Dissection Of The Amygdala And Its Relevance To Autism.

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14606693&dopt=Abstract

 

Zirlinger M, Anderson D.

Division of Biology, California Institute of Technology, Pasadena, CA 91125, USA.

 

The limbic system, and in particular the amygdala, have been implicated in autism.

      The amygdala is a complex structure that in rodents consists of at least 12 different nuclei or subnuclei.

      A comparative analysis of amygdala neuroanatomy in normal vs.

      autistic brains would be aided by the availability of molecular markers to unambiguously recognize these different amygdala substructures.

      Here we report on the development of methods to identify genes enriched in the central, lateral and medial nuclei of the rodent amygdala.

      Our results suggest that laser-capture microdissection of specific amygdala subnuclei, when combined with linear amplification of cRNA probes for oligonucleotide microarray hybridization, can efficiently identify genes whose expression is confined to these substructures.

      Importantly, many of these genes were missed in previous gene expression-profiling experiments using whole amygdala tissue.

      The isolation of human orthologs of these subnucleus-specific genes, and/or the application of these methods directly to human tissue, may provide useful markers for characterizing neuropathological correlates of autism, as well as for identifying molecular differences between normal and autistic brains.

      PMID: 14606693 [PubMed - in process]

* * *

 

The Amygdala And Autism: Implications From Non-Human Primate Studies. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14606694&dopt=Abstract

 

Amaral DG, Bauman MD, Schumann CM.

 

Department of Psychiatry and Behavioral Sciences and Center for Neuroscience, The M.I.N.D. Institute, University of California at Davis, Davis, CA 95817, USA. dgamaral@ucdavis.edu

 

Brothers (1990) has proposed that the amygdala is an important component of the neural network that underlies social behavior.

      Kemper and Bauman (1993) identified neuropathology in the amygdala of the postmortem autistic brain.

      These findings, along with recent functional neuroimaging data, have led Baron-Cohen et al.

      (2000) to propose that dysfunction of the amygdala may be responsible, in part, for the impairment of social behavior that is a hallmark feature of autism.

      Recent data from studies in our laboratory on the effects of amygdala lesions in the adult and infant macaque monkey do not support a fundamental role for the amygdala in social behavior.

      If the amygdala is not essential for the component processes of social behavior, as seems to be case in both non-human primates and selected patients with bilateral amygdala damage, then it is unlikely to be the primary substrate for the impaired social behavior of autism.

      However, damage to the amygdala does have an effect on a monkey's response to normally fear-inducing stimuli, such as snakes, and removes a natural reluctance to engage novel conspecifics in social interactions.

      These findings lead to the conclusion that an important role for the amygdala is in the detection of threats and mobilizing an appropriate behavioral response, part of which is fear.

      Interestingly, an important comorbid feature of autism is anxiety (Muris et al. 1998). If the amygdala is pathological in subjects with autism, it may contribute to their abnormal fears and increased anxiety rather than their abnormal social behavior.

      PMID: 14606694 [PubMed - in process]

* * *

 

Bioinformatic Analysis Of Autism Positional Candidate Genes Using Biological Databases And Computational Gene Network Prediction.

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14606695&dopt=Abstract

Yonan AL, Palmer AA, Smith KC, Feldman I, Lee HK, Yonan JM, Fischer SG, Pavlidis P, Gilliam TC. Columbia Genome Center, Columbia University, New York, NY 10032, USA.

 

Common genetic disorders are believed to arise from the combined effects of multiple inherited genetic variants acting in concert with environmental factors, such that any given DNA sequence variant may have only a marginal effect on disease outcome.

      As a consequence, the correlation between disease status and any given DNA marker allele in a genomewide linkage study tends to be relatively weak and the implicated regions typically encompass hundreds of positional candidate genes.

      Therefore, new strategies are needed to parse relatively large sets of 'positional' candidate genes in search of actual disease-related gene variants.

      Here we use biological databases to identify 383 positional candidate genes predicted by genomewide genetic linkage analysis of a large set of families, each with two or more members diagnosed with autism, or autism spectrum disorder (ASD).

      Next, we seek to identify a subset of biologically meaningful, high priority candidates.

      The strategy is to select autism candidate genes based on prior genetic evidence from the allelic association literature to query the known transcripts within the 1-LOD (logarithm of the odds) support interval for each region.

      We use recently developed bioinformatic programs that automatically search the biological literature to predict pathways of interacting genes (PATHWAYASSIST and GENEWAYS).

      To identify gene regulatory networks, we search for coexpression between candidate genes and positional candidates.

      The studies are intended both to inform studies of autism, and to illustrate and explore the increasing potential of bioinformatic approaches as a compliment to linkage analysis.

      PMID: 14606695 [PubMed - in process]

* * *

 

[Hearing Impairment And Psychopathological Disorders In Children And Adolescents. Review of the recent literature] [Article in French]

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14615703&dopt=Abstract

 

Bailly D, Dechoulydelenclave MB, Lauwerier L.

Federation de Psychiatrie de l'Enfant et de l'Adolescent, Hopital Sainte-Marguerite, 270, boulevard Sainte-Marguerite, Faculte de Medecine de Marseille, 13009 Marseille.

 

OBJECTIVE: - Hearing impairment is a multifaceted condition with medical and social aspects.

      If the neuropsychiatric impact of deafness on children has been investigated by researchers from a variety of fields and backgrounds, their conclusion is that children with hearing impairment follow many different developmental pathways.

      The aim of this paper is to examine the relationships between hearing impairment and mental health and the effect of impaired communication on family development.

      Method - From a review of the literature, the authors examine the relationships between hearing impairment and mental disorders in children and adolescents in terms of prevalence, clinical features and etiological factors.

      The fami-ly dynamics and the parents-child interactions were also explored.

      RESULTS: - The assessment of psychiatric disorders in hearing-impaired children sets some methodological pro-blems.

      Accurate evaluation is hampered by the immature language exhi-bited by many hearing-impaired children and by the difficulties that may be encountered in establishing rapport if the child does not understand the examiner's verbal exchanges.

      Several authors point out the lack of communication skills and experiences with hearing-impaired children on the part of many examiners.

      In addition, delays have been observed for the development of social maturity in hearing-impaired children and the parents' descriptions may reflect their own worries, rather than the emotional-behavioral functioning of the child.

      The measurement of psychiatric symptoms is then compromised insofar as many of the assessment procedures are highly verbal and were standardized for normal-hearing children.

      These difficulties may explain that the pre-valence rates of mental disorders in hearing-impaired children and adolescents found in the literature vary from 15% to 60%.

      If autism and deafness may both confound each others' dia-gnosis, several studies also point out the high comorbidity observed between these 2 conditions.

      The significance of this association remains unclear.

      Many of the authors conclude that hearing impairment is unlikely to be an etiological factor in autism.

      However, auditory impairment may be a marker for brain damage in autism.

      Although some studies showed high rates of depression and anxiety disorders, particularly social phobias, in deaf and hard-of-hearing children and adolescents, most of the studies conclude that the prevalence of affective disorders in hearing-impaired children and adolescents is comparable with estimates of prevalence for hearing young people.

      A number of studies have suggested that deaf children show greater degrees of impulsivity than hearing children.

      However, it seems that this background of greater impulsivity does not lead to higher rates of attention-deficit/hyperactivity disorder (ADHD) among deaf children.

      Using standardized instruments to estimate the prevalence of ADHD in this population, recent studies conclude that deaf children with hereditary deafness are not at greater risk of developing ADHD but that children with acquired deafness are, and that this difference is probably related to the medical conditions and family climates distinguishing these two groups.

      Psychotic disorders are no more common among hearing-impaired young people than among young people with normal hearing.

      However, some recent studies showed that the presentation of schizophrenia can differ in deaf people because of the high frequency of visual hallucinations observed in them.

      Lastly, if primitive personality has been described as being more prevalent among hearing-impaired children and adolescents, most of the studies found a normal range of emotional-behavioral functioning in them.

      In summary, if varying incidences of emotional disturbances and behavioral problems have been reported for hearing-impaired children and adolescents, except autism, it seems that children with hearing impairment experience the same range of mental health problems as hearing children.

      A variety of demographic, medical and educational factors were investigated as possible etiological factors for the psychiatric disorders observed in hearing-impaired children.

      Factors such as medical conditions, degree of deafness, communication ability and social deprivation may play a role.

      However, many studies also emphasize that a number of other variables, including educational methods, parental adaptation and parental support, may have an impact, positive or negative, on the deve-lopment of the hearing-impaired child.

      By this way, numerous investigations have shown that deaf children of deaf parents attain better emotional and cognitive development than do deaf children of hearing parents.

      CONCLUSION: - A number of questions remain about the neuropsychiatric and psychosocial aspects of hearing-impairment in children.

      For instance, few studies have been conducted to examine the impact of the different methods of communication and education on the psychosocial adjustment of deaf children.

      However, this review clearly show that appropriate and effective management can occur only when the mental health professionals are know-ledgeable and sensitive to the unique characteristics and experiences of hearing-impaired children and adolescents.

      PMID: 14615703 [PubMed - in process]

 

 

 

          _______________________________________________________

 

             LOOKING FOR SOMETHING - ANYTHING - ABOUT AUTISM?

 

             Search The Most Complete Autism News & Info Database

              The Schafer Autism Report -- Updated Fresh Daily

             http://groups.yahoo.com/group/-AuTeach/messages

 

               . . .OR ASK A NEIGHBOR: Free Readers' Posts

               http://home.sprynet.com/~schafer/frm/postsc.htm

         ________________________________________________________

 

 

 

* * *

 

Increases In Social Initiation Toward An Adolescent With Autism: Reciprocity Effects.

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14622895&dopt=Abstract

 

McDonald ME, Hemmes NS.

The Graduate Center and Queens College, City University of New York, and The Genesis School, 270 Washington Ave., Suite 6, 11804, Plainview, NY, USA

 

Level of spontaneous social initiating by three adult caregivers toward a youth with autism was studied during a program to increase the youth's level of social initiating.

      The adult participants were three staff members of a program for individuals with autism; they were assigned to the classroom of the youth participant, but none was directly involved in his educational program.

      Under a multiple-baseline across subject design, in combination with a multi-element design, the youth's social initiations toward each adult were systematically reinforced.

      Two sessions were conducted daily: one in which prompts, token reinforcers, and verbal praise for the youth's social behavior were presented (baseline and training sessions), and one in which prompts were absent and only verbal praise was presented (probe sessions).

      Frequency of spontaneous initiating toward the youth increased for each adult during treatment when the youth's frequency of initiating toward a given adult increased.

      It was higher during training vs. probe sessions, where level of social initiating by the youth was also higher.

      PMID: 14622895 [PubMed - in process]

* * *

 

Infections, Toxic Chemicals And Dietary Peptides Binding To Lymphocyte Receptors And Tissue Enzymes Are Major Instigators Of Autoimmunity In Autism.

 

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_ui

ds=14611720&dopt=Abstract

Vojdani A, Pangborn JB, Vojdani E, Cooper EL.

Lab. Comparative Immunology, Dept. Neurobiology, UCLA Medical Center, Los Angeles, CA, USA.

 

Similar to many complex autoimmune diseases, genetic and environmental factors including diet, infection and xenobiotics play a critical role in the development of autism.

      In this study, we postulated that infectious agent antigens such as streptokinase, dietary peptides (gliadin and casein) and ethyl mercury

(xenobiotic) bind to different lymphocyte receptors and tissue enzyme (DPP IV or CD26).

      We assessed this hypothesis first by measuring IgG, IgM and IgA antibodies against CD26, CD69, streptokinase (SK), gliadin and casein peptides and against ethyl mercury bound to human serum albumin in patients with autism.

      A significant percentage of children with autism developed anti-SK, anti-gliadin and casein peptides and anti-ethyl mercury antibodies, concomitant with the appearance of anti-CD26 and anti-CD69 autoantibodies.

      These antibodies are synthesized as a result of SK, gliadin, casein and ethyl mercury binding to CD26 and CD69, indicating that they are specific.

      Immune absorption demonstrated that only specific antigens, like CD26, were capable of significantly reducing serum anti-CD26 levels.

      However, for direct demonstration of SK, gliadin, casein and ethyl mercury to CD26 or CD69, microtiter wells were coated with CD26 or CD69 alone or in combination with SK, gliadin, casein or ethyl mercury and then reacted with enzyme labeled rabbit anti-CD26 or anti-CD69.

      Adding these molecules to CD26 or CD69 resulted in 28-86% inhibition of CD26 or CD69 binding to anti-CD26 or anti-CD69 antibodies.

      The highest % binding of these antigens or peptides to CD26 or CD69 was attributed to SK and the lowest to casein peptides.

      We, therefore, propose that bacterial antigens (SK), dietary peptides (gliadin, casein) and Thimerosal (ethyl mercury) in individuals with pre-disposing HLA molecules, bind to CD26 or CD69 and induce antibodies against these molecules.

      In conclusion, this study is apparently the first to demonstrate that dietary peptides, bacterial toxins and xenobiotics bind to lymphocyte receptors and/or tissue enzymes, resulting in autoimmune reaction in children with autism.

      PMID: 14611720 [PubMed - in process]

 

_________________________________________________________________

Lenny Schafer, Editor mailto:edit@doitnow.com

Edward Decelie Debbie Hosseini Richard Miles Ron Sleith Kay Stammers

 

 

_______________________________________________

SAReport mailing list

SAReport@envirolink.org

 

Return to Vaccination News Home Page (for best results, right click to "open in new window")

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.